AstraZeneca gets EMA approval for Vaxzevria booster dose in adults
The EC approval follows positive CHMP recommendation in patients previously vaccinated with Vaxzevria or an EU-approved mRNA Covid-19…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
24 May 22
The EC approval follows positive CHMP recommendation in patients previously vaccinated with Vaxzevria or an EU-approved mRNA Covid-19…
23 May 22
The FDA approval is based on data from a Phase 3 trial, conducted in two parts, Part A…
23 May 22
Fosun Pharma will obtain an exclusive license to VerImmune’s lead AIR-ViP product candidate, VERI-101, in Mainland China, Hong…
20 May 22
Abevmy marks the third oncology biosimilar to be launched by the partnership in Canada, following Ogivri (bTrastuzumab) in…
20 May 22
The CDSCO approval is based on results from the Phased 3 EMPEROR-Preserved trial which evaluated Jardiance 10mg, compared…
19 May 22
The Phase 1 clinical trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for…
19 May 22
The US Centres for Disease Control and Prevention (CDC) has confirmed the first monkeypox infection, after conducting a…
18 May 22
The expanded EUA is based on data, showing booster dose of Pfizer-BioNTech Covid-19 Vaccine induced superior immune response…
18 May 22
AstraZeneca will obtain an exclusive global licence to develop, manufacture and commercialise pre-clinical Covid-19 antibodies engineered by RQ…
17 May 22
Upon receiving the FDA approval, which is subject to meeting the initial requirements for start-up, Abbott can restart…